Antifungal azoles as tetracycline resistance modifiers in Staphylococcus aureus

N Mahey, R Tambat, DK Verma… - Applied and …, 2021 - Am Soc Microbiol
Staphylococcus aureus has developed resistance to antimicrobials since their first use. The
S. aureus major facilitator superfamily (MFS) efflux pump Tet (K) contributes to resistance to …

Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics

BD Schindler, P Jacinto, GW Kaatz - Future microbiology, 2013 - Future Medicine
The emergence of multidrug-resistant Staphylococcus aureus coupled with a declining
output of new antibiotic treatment options from the pharmaceutical industry is a growing …

[HTML][HTML] Ferulic acid derivatives inhibiting Staphylococcus aureus tetK and MsrA efflux pumps

PG Pinheiro, GMP Santiago, FEF da Silva… - Biotechnology …, 2022 - Elsevier
Background Bacterial resistance to multiple drugs has recently emerged as a serious health
problem. Concomitantly, the characterization of new substances with potential antimicrobial …

Synthesis and Evaluation of 2‐Aminothiophene Derivatives as Staphylococcus aureus Efflux Pump Inhibitors

RMD da Cruz, R Zelli, S Benhsain… - …, 2020 - Wiley Online Library
aminothiophene derivatives (2AT) in which the thiophene ring is fused with a cycloalkyl or a
N‐acylated piperidine ring by positions 5 and 6 and carrying a 3‐carbethoxy group were …

Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance

E Rampacci, T Felicetti, D Pietrella… - Journal of …, 2022 - academic.oup.com
Objectives To perform an in silico prediction of drug efflux pumps (EPs) in Staphylococcus
pseudintermedius and investigate their role in conferring resistance to antibiotic and biocidal …

Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus

SAAM Abdel-Karim, AMA El-Ganiny, MA El-Sayed… - Plos one, 2022 - journals.plos.org
Background and objectives Staphylococcus aureus is an opportunistic pathogen that causes
wide range of nosocomial and community-acquired infections which have spread worldwide …

Efflux pump mediated antimicrobial resistance by staphylococci in health-related environments: challenges and the quest for inhibition

A Dashtbani-Roozbehani, MH Brown - Antibiotics, 2021 - mdpi.com
The increasing emergence of antimicrobial resistance in staphylococcal bacteria is a major
health threat worldwide due to significant morbidity and mortality resulting from their …

Inhibition of efflux pumps by monoterpene (α-pinene) and impact on Staphylococcus aureus resistance to tetracycline and erythromycin

PR Freitas, ACJ de Araújo, CR Barbosa… - Current Drug …, 2021 - ingentaconnect.com
Introduction: Infectious diseases have been responsible for an increasing number of deaths
worldwide. Staphylococcus aureus has been recognized as one of the most notable …

Screening a repurposing library for potentiators of antibiotics against Staphylococcus aureus biofilms

F Van den Driessche, G Brackman… - International journal of …, 2017 - Elsevier
Staphylococcus aureus biofilms are involved in a wide range of infections that are extremely
difficult to treat with conventional antibiotic therapy. We aimed to identify potentiators of …

A novel mechanism of action of ketoconazole: inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus

RM Abd El-Baky, T Sandle, J John… - Infection and Drug …, 2019 - Taylor & Francis
Background The rapid emergence of antimicrobial resistance among Gram-positive
organisms, especially staphylococci, has become a serious clinical challenge. Efflux …